SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as investors digest recent financial results, with community chatter focused on valuation concerns after a significant run-up. While some bulls remain optimistic about the company's AI prospects and long-term growth, bears point to a high P/E ratio and potential market correction. News of a major investor taking a short position is also contributing to the conversation.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer ($PFE) is trending due to significant trading volume and speculation around potential acquisitions and earnings. Community discussions revolve around Michael Burry's call option positions and Pfizer's ongoing legal battles with Novo Nordisk over Metsera. Some traders anticipate a breakout post-earnings, while others remain skeptical, citing past performance and heavy debt.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending due to positive earnings reports and increasing discussion around its partnerships, especially regarding autonomous vehicle technology with companies like NVIDIA and Lucid. The community is actively discussing the potential for robotaxis and the impact on Uber's future profitability, though some express frustration with the stock's price action despite positive news. Some traders are wary of a potential downside setup, while others are aggressively buying calls in anticipation of a significant move upwards leading up to earnings.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending due to a sharp decline following confirmatory trial results for its PMO therapies; while the trial missed its primary endpoint, the company highlights COVID-related impacts and plans to discuss a path to traditional approval with the FDA. The community is debating the significance of the trial results, the future of PMO therapies, and the potential impact on the company's valuation, with some viewing the sell-off as an overreaction and a buying opportunity given Sarepta's revenue and pipeline.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending due to its acquisition of Lanteris Space Systems, a move seen as transforming the company into a major competitor in the aerospace and defense sector. The community is discussing the combined revenue, backlog, and expanded capabilities into new mission types and government programs. This acquisition is viewed as a shift in the valuation story, with some anticipating a rotation into smaller, innovative players in the space industry.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amid discussions about its upcoming earnings report and potential partnerships, particularly with Novo Nordisk ($NVO). Community members are debating the company's growth prospects, with some highlighting its expansion into new markets and others expressing concern over profitability and insider selling. Analyst ratings are mixed, with some firms setting high price targets while others have a more cautious outlook.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY is trending amidst community debates about its long-term potential and current market performance, with some expressing concerns about its ranking and past hype, while others remain hopeful for future gains related to data management and AI. Discussions include technical analysis with an emphasis on key resistance levels, while some traders discuss longing or shorting the token. The community speculates on potential market catalysts, including developments with Janction and the J-Credit system.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending amid speculation about privacy coins and potential rotation from Bitcoin, with community members pointing to its limited supply and privacy features. Some traders are highlighting ZEC's strong performance relative to other cryptocurrencies and anticipating further gains, while others caution about overbought conditions and potential pullbacks. Discussions include potential price targets, comparisons to Bitcoin, and the upcoming anniversary catalyst.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is trending due to a mixed earnings report, beating EPS expectations but falling slightly short on revenue, sparking debate among investors about its valuation. While the company raised its 2025 adjusted EPS guidance and highlighted record revenue, community sentiment is divided, with some questioning the market's negative reaction and others pointing to potential overvaluation or broader market concerns. Community members are also discussing call/put walls and potential market manipulation.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending after OpenAI announced a partnership to enable in-app purchases within ChatGPT, potentially driving more traffic to SHOP merchants. Community members are discussing the implications for e-commerce and SHOP's competitive positioning, with some highlighting the company's growth prospects and others questioning its valuation. The stock is testing new 52-week highs as investors assess the impact of this development on Shopify's long-term growth and AI strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dalal Street opened under pressure once again on Friday, with all major sectoral indices declining. The benchmark&nbsp;Indian indices are on track for a fifth consecutive session of losses.At 10:15 a.m. IST, the <a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50 index</a> was down 0.41% at 24,788.55, while the Sensex fell 0.45% to 80,796.30. 36 of the 50 constituents of the Nifty50 index were trading lower.Markets were dragged lower by strong selling in pharmaceutical stocks after US President Donald Trump<a href="https://stocktwits.com/news-articles/markets/equity/trump-shocks-pharma-with-100-tariff-on-imported-drugs-unless-companies-build-in-america/chDVGpjR3I2"> declared</a> a 100% tariff on branded and patented pharmaceutical products starting Oct. 1.The <a href="https://stocktwits.com/symbol/NIFTYPHARMA.NSE">Nifty Pharma index</a> was down 2.3% in early trade, with <a href="https://stocktwits.com/symbol/NATCOPHARM.NSE">Natco Pharma</a> (-4.7%), <a href="https://stocktwits.com/symbol/LAURUSLABS.NSE">Laurus Labs</a> (-3.7%), and <a href="https://stocktwits.com/symbol/BIOCON.NSE">Biocon</a> (-3.3%) leading the declines. Sun Pharma was down 2.9%, while Dr Reddy's fell 1.2%.The United States remains the largest export destination for Indian pharmaceuticals, accounting for 31% of the country's $27.9 billion pharma exports in FY24, as per data from the Pharmaceuticals Export Promotion Council of India.Broader markets followed a similar trend, with the <a href="https://stocktwits.com/symbol/NIFTYMIDCAP100.NSE">Nifty Midcap 100 index</a> falling 0.81% and the <a href="https://stocktwits.com/symbol/NIFTYSMLCAP100.NSE">Nifty Smallcap 100 index</a> slumping 1.2%.Retail sentiment for the Nifty50 remained 'bearish' as the selloffs continued. It was 'bullish' last week.<figure class="image"><img style="aspect-ratio:916/96;" src="https://news.stocktwits-cdn.com/Nifty_50_png_45d26ed85d.webp" alt="Nifty 50.png" width="916" height="96"><figcaption>Nifty 50's Sentiment Meter and Message Volumes at 10:15 a.m. IST on September 26 | Source: Stocktwits</figcaption></figure>Stock Watch<a href="https://stocktwits.com/symbol/SUNPHARMA.NSE">Sun Pharma</a> was the biggest laggard on the Nifty 50 index, followed by IT majors <a href="https://stocktwits.com/symbol/INFY.NSE">Infosys</a> (-1.7%), <a href="https://stocktwits.com/symbol/WIPRO.NSE">Wipro</a> (-1.65%), and <a href="https://stocktwits.com/symbol/WIPRO.NSE">Tech Mahindra</a> (-1.6%).<a href="https://stocktwits.com/symbol/CARYSIL.NSE">Carysil</a>, a manufacturer and exporter of home furnishing products, fell nearly 8% after Trump announced a 50% tariff on kitchen cabinets and bathroom vanities, and 30% on upholstered furniture.Shares of beleaguered telecom firm <a href="https://stocktwits.com/symbol/IDEA.NSE">Vodafone Idea</a> dropped 3% ahead of the Supreme Court hearing on the company's plea against the central government's adjusted gross revenue (AGR) demand.On the other hand, <a href="https://stocktwits.com/symbol/TATAMOTORS.NSE">Tata Motors</a> gained 2.2% after its UK subsidiary, Jaguar Land Rover (JLR), announced progress in restoring digital systems that were affected by a cyberattack earlier this month. The stock had shed nearly 3% in the previous session after reports emerged that the cyberattack could cost the company around £2 billion.<a href="https://stocktwits.com/symbol/RITES.NSE">RITES</a> surged 5.6% after the public sector undertaking received a Letter of Award from Talis Logistics, South Africa, worth $18 million for supplying and commissioning overhauled Cape gauge ALCO diesel-electric locomotives.<a href="https://stocktwits.com/symbol/NAZARA.NSE">Nazara Technologies</a> was up 1.5% after the stock began trading ex-bonus and ex-split. The company had recently announced a 1:1 bonus issue and a 1:2 stock split.Bearish ChartsTechnically, the 24,900-24,920 zone is a key support area&nbsp;for the Nifty where a short-term pullback could occur. If this level fails to hold, the next significant support lies at 24,800–24,760, coinciding with the 100-day exponential moving average (EMA) and the 61.8% Fibonacci retracement, said SEBI-registered&nbsp;<a href="https://stocktwits.com/BHARATSHARMA_StockAce_RA">analyst Bharat Sharma</a><stembedurl>https://stocktwits.com/BHARATSHARMA_StockAce_RA/message/629997553</stembedurl>A recovery from these levels will face stiff resistance near 25,000, and reclaiming this mark will be challenging without strong buying momentum.In the near term, the market is likely to witness "sell on rise" opportunities below 25,000 as sentiment remains weak, Sharma said.For Nifty, Immediate intraday support is seen at 24,880, below which the index could slide toward 24,800–24,760-24,720, the analyst added.Resistance is placed around 24,950, and a breakout above this level could trigger a retest of 25,000 and higher levels up to 25,140. Overall, the positional outlook remains bearish with a cautious eye on a potential pullback, Sharma said.On the charts, Nifty formed a bearish candle, reflecting continued pressure at higher levels. Indicators such as the relative strength index (RSI) have weakened further, suggesting a loss of momentum, while the moving average convergence/divergence (MACD) remains above the signal line but is showing early signs of fatigue, according to ASEBI-registered&nbsp;<a href="https://stocktwits.com/Ca_mayankchandel">analyst Mayank Singh Chandel</a>.<stembedurl>https://stocktwits.com/Ca_mayankchandel/message/630006102</stembedurl>Support is now at 24,800-24,750, aligned with the 61.8% retracement and 100-day EMA. A breakdown here could push the index toward 24,700 - 24,600. Resistance lies at 25,000, with a stronger supply zone at 25,100 - 25,150, Chandel said.Derivatives data confirm these levels, with heavy call writing at 25,000 and 25,100 reinforcing overhead resistance, while fragile support remains at 24,800 and 24,900, he added.Overall, the trend favors bears unless Nifty reclaims and sustains above 25,000. Until then, further declines toward the 24,600 zone cannot be ruled out, the analyst said.Nifty faces intraday resistance between 25,009 - 25,075, while support is seen around 24,738–24,800, said <a href="https://stocktwits.com/aymr_sebi_ra">A&amp;Y Market Research</a>.<stembedurl>https://stocktwits.com/aymr_sebi_ra/message/630079301</stembedurl>Bank Nifty has resistance levels at 55,055 - 55,168 and support near 54,492 - 54,587. These ranges will likely guide market moves, with a breakout or breakdown signaling the next direction.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

(Photo by Indranil Aditya/NurPhoto via Getty Images)

Sensex, Nifty Today: Indian Stocks Face 5th Day Of Losses On Trump's Pharma Tariffs — SEBI RAs Flag Key Levels to Watch

The Nifty Pharma index was down 2.3% in early trade, with Natco, Biocon, and Laurus Labs among the top laggards.

Equity

Stock Radar: PNC Infratech, Zydus Life, NBCC, Awfis Space, Vodafone Idea, UPL in focus on Wednesday

UPL, Kirloskar Brothers, ICICI Prudential Life Insurance Company, SBI Cards and Payment Services, Aditya Birla Capital, Wipro, and IndiaMART InterMESH will also be in focus on August 28.

Carysil Ltd. engages in the manufacture and distribution of kitchen sinks, faucets, and food waste disposers. It also offers granite sinks, stainless steel sinks, and appliances. It also offers maintenance and repair services. The company was founded by Ashwin Mohanlal Parekh on January 19, 1987 and is headquartered in Bhavnagar, India.

Current Price	980.00
Prev Close	984.00
Open	993.75
Dividend Yield	0.38%
50-Day Moving Average	900.68
Beta	-0.01
Avg. Volume	99,936.67
PE Ratio	39.67

52-Week High	992.90
52-Week Low	482.30
Market Capitalization	28.08B
EPS (Annual)	22.76
Price to Book	5.33
Revenue Per Employee	5.81M
Enterprise Value/EBITDA	N/A

CARYSIL.NSE
Carysil Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest CARYSIL.NSE News

CARYSIL.NSECarysil Ltd.